Skip to main content
Erschienen in: Cancer Causes & Control 9/2013

01.09.2013 | Original paper

Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study

verfasst von: Ping-Ping Bao, Ying Zheng, Sarah Nechuta, Kai Gu, Hui Cai, Peng Peng, Xiao-Ou Shu, Wei Lu

Erschienen in: Cancer Causes & Control | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Metabolic syndrome (MetS) is an established risk factor for cardiovascular diseases and mortality. Limited data are available on the prevalence of MetS and its association with exercise among breast cancer survivors. The present study included 1,696 breast cancer survivors from the Shanghai Breast Cancer Survival Study, a population-based prospective cohort study conducted between April 2002 and October 2011 in Shanghai, China. All women had a physical examination taken at study clinic approximately 60 months post-diagnosis. Exercise was assessed at approximately 6, 18, 36, and 60 months post-diagnosis. Information on medical history, tumor characteristics, cancer treatment, anthropometrics, and lifestyle was collected at study enrollment. Associations between exercise and MetS at 60 months post-diagnosis were evaluated with multivariable logistic regression models. The mean age of the study population was 56.68 at 60-month survey, and the mean follow-up since cancer diagnosis was 63.66 months. The prevalence of MetS using National Cholesterol Education Program Adult Treatment Panel III criteria at approximately 60 months after diagnosis was 33.14 %. Among overweight and obesity breast cancer survivors (body mass index (BMI) ≥ 25 kg/m2 at baseline), the prevalence was 55.18 %. The most common type of exercise in this population was walking (45.40 %) at baseline. Exercise participation between 6 and 60 months post-diagnosis was inversely associated with the prevalence of MetS with the adjusted odds ratio (OR) for exercise participation of ≥3.5 h/week (30 min/day) being 0.69 (95 % confidence interval (CI) 0.48–0.98). In addition consistent exercise participation reduced the prevalence of MetS (adjusted OR 0.70 (95 % CI 0.50–1.00). Associations of exercise with MetS were not modified by baseline waist circumference, BMI, comorbidity, baseline menopausal status, TNM stage, cancer treatment, or ER/PR status (p interactions >0.05). Regular and persistent exercise after cancer diagnosis, even at low-to-moderate intensity level, decreases the prevalence of MetS among long-term breast cancer survivors.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D (2010) GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer, Lyon Ferlay J, Shin HR, Bray F, Forman D (2010) GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide, International Agency for Research on Cancer, Lyon
2.
Zurück zum Zitat Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241PubMedCrossRef Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241PubMedCrossRef
3.
Zurück zum Zitat Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70–S80PubMedCrossRef Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70–S80PubMedCrossRef
4.
Zurück zum Zitat Maurea N, Coppola C, Ragone G et al. (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med (Hagerstown) Maurea N, Coppola C, Ragone G et al. (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med (Hagerstown)
5.
Zurück zum Zitat de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11:193–203PubMedCrossRef de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA (2010) The metabolic syndrome in cancer survivors. Lancet Oncol 11:193–203PubMedCrossRef
6.
Zurück zum Zitat Denke MA, Pasternak RC (2001) Defining and treating the metabolic syndrome: a primer from the adult treatment panel III. Curr Treat Options Cardiovasc Med 3:251–253PubMedCrossRef Denke MA, Pasternak RC (2001) Defining and treating the metabolic syndrome: a primer from the adult treatment panel III. Curr Treat Options Cardiovasc Med 3:251–253PubMedCrossRef
7.
Zurück zum Zitat Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28:195–214PubMedCrossRef Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28:195–214PubMedCrossRef
8.
Zurück zum Zitat Redig AJ, Munshi HG (2010) Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med 123(87):e1–e6PubMed Redig AJ, Munshi HG (2010) Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med 123(87):e1–e6PubMed
9.
Zurück zum Zitat Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505–1522PubMedCrossRef Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505–1522PubMedCrossRef
10.
Zurück zum Zitat Jung HS, Myung SK, Kim BS, Seo HG (2012) Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract 95:275–282PubMedCrossRef Jung HS, Myung SK, Kim BS, Seo HG (2012) Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract 95:275–282PubMedCrossRef
11.
Zurück zum Zitat Redig AJ, Munshi HG (2010) Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy. Oncology (Williston Park) 24:839–844 Redig AJ, Munshi HG (2010) Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy. Oncology (Williston Park) 24:839–844
12.
Zurück zum Zitat Patterson RE, Flatt SW, Saquib N et al (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859–865PubMedCrossRef Patterson RE, Flatt SW, Saquib N et al (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859–865PubMedCrossRef
13.
Zurück zum Zitat Dai DF, Hwang JJ, Chen CL et al (2010) Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J Formos Med Assoc 109:716–724PubMedCrossRef Dai DF, Hwang JJ, Chen CL et al (2010) Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J Formos Med Assoc 109:716–724PubMedCrossRef
14.
Zurück zum Zitat Nguyen TH, Tang HK, Kelly P, van der Ploeg HP, Dibley MJ (2010) Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam. BMC Public Health 10:141PubMedCrossRef Nguyen TH, Tang HK, Kelly P, van der Ploeg HP, Dibley MJ (2010) Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam. BMC Public Health 10:141PubMedCrossRef
15.
Zurück zum Zitat Harralson TL, Uplinger N, McLaughlin M (2010) Increasing physical activity: a step toward controlling metabolic syndrome. Diabetes Educ 36:70–71PubMedCrossRef Harralson TL, Uplinger N, McLaughlin M (2010) Increasing physical activity: a step toward controlling metabolic syndrome. Diabetes Educ 36:70–71PubMedCrossRef
16.
Zurück zum Zitat van Waas M, Neggers SJ, van der Lelij AJ, Pieters R, van den Heuvel-Eibrink MM (2010) The metabolic syndrome in adult survivors of childhood cancer, a review. J Pediatr Hematol Oncol 32:171–179PubMedCrossRef van Waas M, Neggers SJ, van der Lelij AJ, Pieters R, van den Heuvel-Eibrink MM (2010) The metabolic syndrome in adult survivors of childhood cancer, a review. J Pediatr Hematol Oncol 32:171–179PubMedCrossRef
17.
Zurück zum Zitat Thomson CA, Thompson PA, Wright-Bea J, Nardi E, Frey GR, Stopeck A (2009) Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt) 18:2041–2047CrossRef Thomson CA, Thompson PA, Wright-Bea J, Nardi E, Frey GR, Stopeck A (2009) Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt) 18:2041–2047CrossRef
18.
Zurück zum Zitat Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499–502PubMedCrossRef Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499–502PubMedCrossRef
19.
Zurück zum Zitat Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51PubMedCrossRef Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51PubMedCrossRef
20.
Zurück zum Zitat Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238PubMedCrossRef Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238PubMedCrossRef
21.
Zurück zum Zitat Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093–1100PubMedCrossRef Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093–1100PubMedCrossRef
22.
Zurück zum Zitat Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132PubMedCrossRef Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132PubMedCrossRef
23.
Zurück zum Zitat Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443PubMedCrossRef Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443PubMedCrossRef
24.
Zurück zum Zitat Epplein M, Zheng Y, Zheng W et al (2011) Quality of life after breast cancer diagnosis and survival. J Clin Oncol 29:406–412PubMedCrossRef Epplein M, Zheng Y, Zheng W et al (2011) Quality of life after breast cancer diagnosis and survival. J Clin Oncol 29:406–412PubMedCrossRef
25.
Zurück zum Zitat Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59:274–280PubMedCrossRef Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59:274–280PubMedCrossRef
26.
Zurück zum Zitat Matthews CE, Shu XO, Yang G et al (2003) Reproducibility and validity of the Shanghai Women’s Health Study physical activity questionnaire. Am J Epidemiol 158:1114–1122PubMedCrossRef Matthews CE, Shu XO, Yang G et al (2003) Reproducibility and validity of the Shanghai Women’s Health Study physical activity questionnaire. Am J Epidemiol 158:1114–1122PubMedCrossRef
27.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef
28.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504PubMedCrossRef Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504PubMedCrossRef
29.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef
30.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef
31.
Zurück zum Zitat Irwin ML, Crumley D, McTiernan A et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97:1746–1757PubMedCrossRef Irwin ML, Crumley D, McTiernan A et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97:1746–1757PubMedCrossRef
32.
Zurück zum Zitat Beasley JM, Kwan ML, Chen WY et al (2012) Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat 131:637–643PubMedCrossRef Beasley JM, Kwan ML, Chen WY et al (2012) Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat 131:637–643PubMedCrossRef
33.
Zurück zum Zitat Andrykowski MA, Beacham AO, Jacobsen PB (2007) Prospective, longitudinal study of leisure-time exercise in women with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev 16:430–438PubMedCrossRef Andrykowski MA, Beacham AO, Jacobsen PB (2007) Prospective, longitudinal study of leisure-time exercise in women with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev 16:430–438PubMedCrossRef
34.
Zurück zum Zitat Littman AJ, Tang MT, Rossing MA (2010) Longitudinal study of recreational physical activity in breast cancer survivors. J Cancer Surviv 4:119–127PubMedCrossRef Littman AJ, Tang MT, Rossing MA (2010) Longitudinal study of recreational physical activity in breast cancer survivors. J Cancer Surviv 4:119–127PubMedCrossRef
35.
Zurück zum Zitat Golbidi S, Mesdaghinia A, Laher I (2012) Exercise in the metabolic syndrome. Oxid Med Cell Longev 2012:349710PubMedCrossRef Golbidi S, Mesdaghinia A, Laher I (2012) Exercise in the metabolic syndrome. Oxid Med Cell Longev 2012:349710PubMedCrossRef
36.
Zurück zum Zitat Misra KB, Endemann SW, Ayer M (2005) Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in northern California. Ethnicity Dis 15:627–634 Misra KB, Endemann SW, Ayer M (2005) Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in northern California. Ethnicity Dis 15:627–634
37.
Zurück zum Zitat Lakka TA, Laaksonen DE (2007) Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32:76–88PubMedCrossRef Lakka TA, Laaksonen DE (2007) Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32:76–88PubMedCrossRef
38.
Zurück zum Zitat McTiernan A (2004) Physical activity after cancer: physiologic outcomes. Cancer Invest 22:68–81PubMedCrossRef McTiernan A (2004) Physical activity after cancer: physiologic outcomes. Cancer Invest 22:68–81PubMedCrossRef
39.
Zurück zum Zitat Nuri R, Kordi MR, Moghaddasi M et al (2012) Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther 8:238–242PubMedCrossRef Nuri R, Kordi MR, Moghaddasi M et al (2012) Effect of combination exercise training on metabolic syndrome parameters in postmenopausal women with breast cancer. J Cancer Res Ther 8:238–242PubMedCrossRef
40.
Zurück zum Zitat Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282–294PubMedCrossRef Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282–294PubMedCrossRef
41.
Zurück zum Zitat Gu K, Chen X, Zheng Y et al (2010) Weight change patterns among breast cancer survivors: results from the Shanghai Breast Cancer Survival Study. Cancer Causes Control 21:621–629PubMedCrossRef Gu K, Chen X, Zheng Y et al (2010) Weight change patterns among breast cancer survivors: results from the Shanghai Breast Cancer Survival Study. Cancer Causes Control 21:621–629PubMedCrossRef
42.
Zurück zum Zitat Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N (2010) Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003–2006). Cancer Causes Control 21:283–288PubMedCrossRef Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N (2010) Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003–2006). Cancer Causes Control 21:283–288PubMedCrossRef
43.
Zurück zum Zitat Wilson DB, Porter JS, Parker G, Kilpatrick J (2005) Anthropometric changes using a walking intervention in African American breast cancer survivors: a pilot study. Prev Chronic Dis 2:A16PubMed Wilson DB, Porter JS, Parker G, Kilpatrick J (2005) Anthropometric changes using a walking intervention in African American breast cancer survivors: a pilot study. Prev Chronic Dis 2:A16PubMed
44.
Zurück zum Zitat Schmitz KH, Courneya KS, Matthews C et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef Schmitz KH, Courneya KS, Matthews C et al (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef
45.
Zurück zum Zitat US Department of Health and Human Services (2008) Physical activity guidelines for Americans. Okla Nurse 53:25 US Department of Health and Human Services (2008) Physical activity guidelines for Americans. Okla Nurse 53:25
Metadaten
Titel
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study
verfasst von
Ping-Ping Bao
Ying Zheng
Sarah Nechuta
Kai Gu
Hui Cai
Peng Peng
Xiao-Ou Shu
Wei Lu
Publikationsdatum
01.09.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 9/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0252-7

Weitere Artikel der Ausgabe 9/2013

Cancer Causes & Control 9/2013 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.